Literature DB >> 20147730

Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.

Hugo H Ortega1, Florencia Rey, Melisa M L Velazquez, Vasantha Padmanabhan.   

Abstract

Prenatal testosterone (T) excess increases ovarian follicular recruitment, follicular persistence, insulin resistance, and compensatory hyperinsulinemia. Considering the importance of insulin in ovarian physiology, in this study, using prenatal T- and dihydrotestosterone (DHT, a nonaromatizable androgen)-treated female sheep, we tested the hypothesis that prenatal androgen excess alters the intraovarian insulin signaling cascade and metabolic mediators that have an impact on insulin signaling. Changes in ovarian insulin receptor (INSRB), insulin receptor substrate 1 (IRS1), mammalian target of rapamycin (MTOR), phosphatidylinositol 3-kinase (PIK3), peroxisome proliferator-activated receptor-gamma (PPARG), and adiponectin proteins were determined at fetal (Days 90 and 140), postpubertal (10 mo), and adult (21 mo) ages by immunohistochemistry. Results indicated that these proteins were expressed in granulosa, theca, and stromal compartments, with INSRB, IRS1, PPARG, and adiponectin increasing in parallel with advanced follicular differentiation. Importantly, prenatal T excess induced age-specific changes in PPARG and adiponectin expression, with increased PPARG expression evident during fetal life and decreased antral follicular adiponectin expression during adult life. Comparison of developmental changes in prenatal T and DHT-treated females found that the effects on PPARG were programmed by androgenic actions of T, whereas the effects on adiponectin were likely by its estrogenic action. These results suggest a role for PPARG in the programming of ovarian disruptions by prenatal T excess, including a decrease in antral follicular adiponectin expression and a contributory role for adiponectin in follicular persistence and ovulatory failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147730      PMCID: PMC2874494          DOI: 10.1095/biolreprod.109.082719

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  71 in total

Review 1.  The insulin signalling pathway.

Authors:  Jose M Lizcano; Dario R Alessi
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

2.  Developmental programming: exogenous gonadotropin treatment rescues ovulatory function but does not completely normalize ovarian function in sheep treated prenatally with testosterone.

Authors:  Teresa L Steckler; James S Lee; Wen Ye; E Keith Inskeep; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2008-06-04       Impact factor: 4.285

3.  Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test.

Authors:  Dimitrios Panidis; Dimitrios Farmakiotis; David Rousso; Georgios Koliakos; Themistoklis Kaltsas; Gerasimos Krassas
Journal:  Fertil Steril       Date:  2005-01       Impact factor: 7.329

4.  Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone.

Authors:  Sergio E Recabarren; Vasantha Padmanabhan; Ethel Codner; Alejandro Lobos; Claudio Durán; Mónica Vidal; Douglas L Foster; Teresa Sir-Petermann
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

Review 5.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

Review 6.  Current concepts of polycystic ovary syndrome.

Authors:  R L Rosenfield
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1997-06

7.  Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.

Authors:  Carla R O Carvalho; José B C Carvalheira; Maria H M Lima; Suzana F Zimmerman; Luciana C Caperuto; Angélica Amanso; Alessandra L Gasparetti; Vainer Meneghetti; Leonardo F Zimmerman; Licio A Velloso; Mario J A Saad
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

8.  Role of adiponectin in regulating ovarian theca and granulosa cell function.

Authors:  Dana V Lagaly; Pauline Y Aad; Juan A Grado-Ahuir; Laura B Hulsey; Leon J Spicer
Journal:  Mol Cell Endocrinol       Date:  2008-01-20       Impact factor: 4.102

Review 9.  Treatment of PCOS with metformin and other insulin-sensitizing agents.

Authors:  Emre Seli; Antoni J Duleba
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

10.  Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin.

Authors:  Ke Ma; Agatha Cabrero; Pradip K Saha; Hideto Kojima; Lan Li; Benny Hung-Junn Chang; Antoni Paul; Lawrence Chan
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

View more
  26 in total

Review 1.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

2.  Developmental programming: gestational testosterone treatment alters fetal ovarian gene expression.

Authors:  Lacey J Luense; Almudena Veiga-Lopez; Vasantha Padmanabhan; Lane K Christenson
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

3.  Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep.

Authors:  Natalia R Salvetti; Hugo H Ortega; Almudena Veiga-Lopez; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2012-07-26       Impact factor: 4.285

4.  Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.

Authors:  Vasantha Padmanabhan; Natalia R Salvetti; Valentina Matiller; Hugo H Ortega
Journal:  Endocrinology       Date:  2014-07-25       Impact factor: 4.736

5.  Developmental Programming: Does Prenatal Steroid Excess Disrupt the Ovarian VEGF System in Sheep?

Authors:  Hugo Héctor Ortega; Almudena Veiga-Lopez; Shilpa Sreedharan; Melisa María del Luján Velázquez; Natalia Raquel Salvetti; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2015-07-15       Impact factor: 4.285

6.  Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles.

Authors:  Almudena Veiga-Lopez; Wen Ye; Vasantha Padmanabhan
Journal:  Fertil Steril       Date:  2012-01-14       Impact factor: 7.329

Review 7.  Developmental Programming of Ovarian Functions and Dysfunctions.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Vitam Horm       Date:  2018-02-22       Impact factor: 3.421

8.  Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez; Carol Herkimer; Bachir Abi Salloum; Jacob Moeller; Evan Beckett; Rohit Sreedharan
Journal:  Endocrinology       Date:  2015-04-28       Impact factor: 4.736

9.  Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression.

Authors:  Almudena Veiga-Lopez; Lacey J Luense; Lane K Christenson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2013-03-22       Impact factor: 4.736

10.  Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep.

Authors:  A Veiga-Lopez; J Moeller; D Patel; W Ye; A Pease; J Kinns; V Padmanabhan
Journal:  Endocrinology       Date:  2013-03-24       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.